Navigating the Ever-Changing Healthcare Landscape: A Journey of Continuous Learning and Strategic Adaptation

Throughout my 30-year healthcare career, I have been fortunate to have had the guidance and support of coaches, mentors, and sponsors. Starting as a pharmacy resident, I became a leader in various pharmaceutical areas and later in other healthcare sectors, eventually rising to Regional Vice President of Clinical and Healthcare Operations and Quality.

In 2016, I embarked on a new adventure as a strategic consultant, working with health systems, payers, and pharmaceutical manufacturers. In 2022, my journey brought me back to the operations and preeminent world of Stanford Healthcare, where I now serve as the Vice President of Pharmacy and Radiology Services and Chief Pharmacy Officer.

My diverse path through the healthcare ecosystem has equipped me with the ability to navigate the complex and ever-evolving healthcare and pharmacy landscape. It has also provided me with invaluable insights, allowing me to anticipate future trends in healthcare services from the ground level of operations to strategic 30,000-foot heights. Throughout this journey, I have maintained a steadfast habit cultivated early in my career to stay current and informed in the ever-evolving world of healthcare.

So, what is this essential habit? Being a continuous learner. Most mornings, I dedicate time to scanning various online journals and news articles within and outside of healthcare. I also spend time reading/listening to books addressing many leadership and management principles. Conferences, webinars, and podcasts are part of my continuous learning toolbox. My goal is to identify trends, entrants, and disruptors (TEDs) in and out of healthcare in the quest for the Quintuple Aim—to provide better care, improved outcomes, reduced costs, and enhanced provider and staff experiences, all while mitigating disparities in care. This is now a habit that team members are adopting.

At present, we are focused on the following TEDs and their impact across the care continuum:

1. Care Delivery Disruptors:

a. The Health Equity Lens: We are looking at organizations that effectively integrate Social Determinants of Health (SDOH) and Health Equity into clinical practice, moving beyond programs to adopt these principles as a lens through which we view health and healthcare.

b. New Entrants into Healthcare: We closely monitor the short- and long-term impacts of non-traditional entrants like CVS, Walmart, Walgreens, Costco, and others as they venture into the healthcare space. These entrants often target the primary care gateway, the first point of contact for individuals seeking health services. This gateway is crucial in shaping a consumer's access to various short- and long-term healthcare resources.

c. The Next Gen Integrators: We are keeping an eye on the organizations taking integration to new heights, including UnitedHealth Group/Optum, CVSHealth/Aetna, Humana/CenterWell, Cigna/Evernorth/ESI, Amazon/One Medical, Risent Health (Kaiser/Geisinger), and others. We are also interested in those entities successfully leveraging technology and AI as an entry point for care to meet consumers where they are and their new expectations for access and flexibility. 

2. People and Workforce Development: In this area, we are exploring organizations focusing on three key areas:

1. Understanding Generational Needs: We are delving into the evolving workforce needs of different generations and exploring how organizations integrate these varying expectations into their workflows and operations.

2. Succession Planning: we are studying strategies for effective succession planning.

3. Building Bench Strength and Developing Leaders: Another key focus area is learning from entities that focus on developing teams and team members to adeptly navigate the constantly changing business and healthcare landscape.

3. Technology & Big Data Enablers: Our attention is drawn to:

a. Emerging Technologies: we are investigating how technologies like AI, analytics, and machine learning are poised to revolutionize health outcomes and enhance medical diagnosis, treatment, healthcare delivery, and the prior authorization process

b. Virtual Care: We are exploring organizations that maximise virtual care, recognizing its permanence and appeal to consumers.

c. Analytics and AI in Therapy Selection: We are in search of entities leveraging analytics and AI to optimize therapy selection, such as the work done a while ago by Meridian Health and COTA in creating the Breast Cancer Lanes of Care, which has improved quality, reduced variation in care, and controlled costs.

4. Legislative & Policy: Given the significant public and political focus on healthcare and drug costs, we closely monitor legislation and bills from CMS and other legislative bodies.

5. Other Pharmacy Specific Topics: In addition to the aforementioned areas, we also pay attention to other key pharmacy-specific TEDs, which include:

a. Drug Shortages: we study processes, resilience-building, and partnerships that organizations employ to address drug shortages while also exploring the potential of AI in this context.

b. Drug Costs: Given the escalating costs of medications, we are focusing on strategies to maximize biomarker testing, high biosimilar usage, and other cost-reduction and innovative strategies.

c. The Evolving Role of Pharmacists and Technicians: we follow the evolving role of pharmacists and technicians in the clinical space, where they continue demonstrating the clinical value and benefits of their practice settings.

Staying up-to-date and informed in these and other areas has empowered my teams to remain current, identify opportunities to bring value, and pivot as needed to pursue excellence in healthcare delivery—on behalf of every person and population served.